CD19 and lymphoma: For example, using models for CD19IL15 CAR-NKs, CD19 CAR-NKs, and NT-NKs calibrated on the lymphoma mouse model dataset in Li et al.23, we projected tumor progression and NK cell population dynamics beyond the endpoint of experimental observation (post mice sacrifice), extending the course to 35 days post-treatment (Figure 4a–b).